AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Non-Ablative and Ablative Fractional Resurfacing: Overview

Description

The presentation offers a comprehensive overview of non-ablative and ablative fractional resurfacing, celebrating its 20-year anniversary since its inception by Rox Anderson and Dieter Mannstein in 2004. It highlights advancements in technology, including various wavelengths and methods for both types of treatments, which have become essential in improving skin conditions like scars, wrinkles, and pigmentation issues. Key focus areas include non-ablative methods utilizing focal point technology that enhances depth targeting, while ablative techniques, although requiring more anesthesia, provide effective results for severe skin concerns. The discussion emphasizes the importance of understanding the histopathology of skin to ensure safety and efficacy in treatments. Various devices available for both non-ablative and ablative procedures are explained, including their indications, advantages, and optimal usage for different skin types and conditions such as actinic keratoses, acne scars, and hypopigmentation. Clinical results presented show promising improvements with minimal downtime for patients. The presentation also explores laser-assisted drug delivery and the synergistic effects of combining lasers with topical treatments, reinforcing the dynamic and evolving nature of fractionated resurfacing in dermatologic practice.

View more

Conclusions

  • Fractional resurfacing has evolved significantly since its inception in 2004, introducing various advancements in non-ablative and ablative technologies.
  • Non-ablative fractional lasers, particularly at 1550 nm and 1927 nm, show promising results for improving skin texture, treating acne scars, and reducing actinic keratosis with minimal downtime.
  • Focal point technology in non-ablative fractional lasers enables targeted treatments with reduced risks of epidermal damage and effective results in skin rejuvenation.
  • Ablative fractional resurfacing provides deeper tissue ablation for conditions such as surgical scars and deeper wrinkles, but may require more extensive anesthesia and has longer recovery times.
  • There is evidence supporting the use of non-ablative fractional treatments for reducing the risk of skin cancers, particularly in patients with a history of actinic keratosis.
  • The combination of fractional lasers with topical therapies can enhance treatment effects and promote better drug absorption into the skin.
  • Fractional resurfacing shows effectiveness in addressing both hyperpigmentation and hypopigmentation issues, normalizing skin tone over time.
  • Overall, both non-ablative and ablative fractional resurfacing techniques are valuable tools in dermatologic and cosmetic treatments, with ongoing research expected to enhance their capabilities and applications.
  • J Am Acad Dermatol. 2013 Jan;68(1):98-102.
  • Benson TA, Hibler BP, Kotliar D, Avram M. Dermatol Surg. 2023 Feb 1;49(2):149-154.
  • Wang JV, Friedman PM, Agron S, Konda A, Parker C, Geronemus RG. Derm Surg 2022;48(8):822-6.
  • Wang JV, Mehrabi JN, Zachary CB, Geronemus RG. Dermatol Surg. 2022 Jan 1;48(1):120-125.
  • Ali Rkein, MD, David Ozog, MD, Jill S. Waibel, MD. Dermatol Surg 2014;40:624-631.
  • Ibrahim O, Ionta S, Depina J, Petrell K, Arndt KA, Dover JS. Dermatol Surg 2019; 00:1-7.
  • Jordan V Wang, Nkemjika Ugonabo, Roy G Geronemus. Dermatol Surg 2022 Feb 1;48(2):258-259.